Inhaled Iloprost in the Treatment of Patients With Pulmonary Hypertension up to 4 Years

CompletedOBSERVATIONAL

Enrollment

118

Participants

Timeline

Start Date

February 3, 2011

Primary Completion Date

March 8, 2017

Study Completion Date

June 18, 2018

Conditions

Pulmonary Hypertension

Interventions

DRUG

Ventavis inhaled (Iloprost, BAYQ6256)

Since this study is an observational, inhaled iloprost dosage and frequency for each patient will be prescribed by physicians as medically required.

Trial Locations (1)

Multiple Locations